FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Niklas Beyersdorf

Research Profile

Chemicals & Drugs

Anatomy

Physiology

Living Beings

Concepts & Ideas

T-Lymphocyte Subsets

Procedures

Bone Marrow Transplantation

Co-author Network

Publications

TOP 3
Andreas Kerstan; Johanna Stoevesandt; Niklas Beyersdorf; Axel Trautmann
Wasp venom immunotherapy expands a subpopulation of CD4(+)CD25+ forkhead box protein 3-positive regulatory T cells expressing the T-cell receptor Vβ2 and Vβ5.1 chains.
Ulrich Hofmann; Thomas Kerkau; Anna Podolskaya; Johannes Weirather; Johann Bauersachs; Niklas Beyersdorf; George Ertl; Stefan Frantz
Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice.
Kai Michaelis; Katrin Wallbrecht; Andreas Kerstan; Niklas Beyersdorf; Cortny Williams; Thomas Kerkau; Xiao-Jing Wang; Thomas Hünig; Michael P Schön
Modulating T cell functions does not alleviate chronic inflammatory skin lesions in K5.TGF beta 1 transgenic mice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Niklas Beyersdorf (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Andreas Kerstan; Johanna Stoevesandt; Niklas Beyersdorf; Axel Trautmann
Wasp venom immunotherapy expands a subpopulation of CD4(+)CD25+ forkhead box protein 3-positive regulatory T cells expressing the T-cell receptor Vβ2 and Vβ5.1 chains.
The Journal of allergy and clinical immunology 2012;130(4):994-6.e3.
2012: Ulrich Hofmann; Thomas Kerkau; Anna Podolskaya; Johannes Weirather; Johann Bauersachs; Niklas Beyersdorf; George Ertl; Stefan Frantz
Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice.
Circulation 2012;125(13):1652-63.
2010: Kai Michaelis; Katrin Wallbrecht; Andreas Kerstan; Niklas Beyersdorf; Cortny Williams; Thomas Kerkau; Xiao-Jing Wang; Thomas Hünig; Michael P Schön
Modulating T cell functions does not alleviate chronic inflammatory skin lesions in K5.TGF beta 1 transgenic mice.
Experimental dermatology 2010;19(5):406-15.
2009: Niklas Beyersdorf; Xin Ding; Thomas Hünig; Thomas Kerkau
Superagonistic CD28 stimulation of allogeneic T cells protects from acute graft-versus-host disease.
Blood 2009;114(20):4575-82.
2008: Niklas Beyersdorf; Xin Ding; Gregor Blank; Kevin M Dennehy; Thomas Kerkau; Thomas Hünig
Protection from graft-versus-host disease with a novel B7 binding site-specific mouse anti-mouse CD28 monoclonal antibody.
Blood 2008;112(10):4328-36.
2007: Niklas Beyersdorf; Xin Ding; Julia K Tietze; Thomas Hanke
Characterization of mouse CD4 T cell subsets defined by expression of KLRG1.
European journal of immunology 2007;37(12):3445-54.
2007: Johannes Grosse; Attila Braun; David Varga-Szabo; Niklas Beyersdorf; Boris Schneider; Lutz Zeitlmann; Petra Hanke; Patricia Schropp; Silke Mühlstedt; Carolin Zorn; Michael Huber; Carolin Schmittwolf; Wolfgang Jagla; Philipp Yu; Thomas Kerkau; Harald Schulze; Michael Nehls; Bernhard Nieswandt
An EF hand mutation in Stim1 causes premature platelet activation and bleeding in mice.
The Journal of clinical investigation 2007;117(11):3540-50.
2006: Niklas Beyersdorf; Karen Balbach; Thomas Hünig; Thomas Kerkau
Large-scale expansion of rat CD4+ CD25+ T(reg) cells in the absence of T-cell receptor stimulation.
Immunology 2006;119(4):441-50.
2006: Denise Tischner; Andreas Weishaupt; Jens van den Brandt; Nora Müller; Niklas Beyersdorf; Chi Wang Ip; Klaus V Toyka; Thomas Hünig; Ralf Gold; Thomas Kerkau; Holger M Reichardt
Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis.
Brain : a journal of neurology 2006;129(Pt 10):2635-47.
2006: Niklas Beyersdorf; Thomas Hanke; Thomas Kerkau; Thomas Hünig
CD28 superagonists put a break on autoimmunity by preferentially activating CD4+CD25+ regulatory T cells.
Autoimmunity reviews 2006;5(1):40-5.
2005: Niklas Beyersdorf; Thomas Hanke; Thomas Kerkau; Thomas Hünig
Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases.
Annals of the rheumatic diseases 2005;64 Suppl 4():iv91-5.
2005: Niklas Beyersdorf; Stefanie Gaupp; Karen Balbach; Jens Schmidt; Klaus V Toyka; Chia-Huey Lin; Thomas Hanke; Thomas Hünig; Thomas Kerkau; Ralf Gold
Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis.
The Journal of experimental medicine 2005;202(3):445-55.
2004: Philipp Ströbel; Andreas Rosenwald; Niklas Beyersdorf; Thomas Kerkau; Olaf Elert; Astrid Murumägi; Niko Sillanpää; Pärt Peterson; Vera Hummel; Peter Rieckmann; Christof Burek; Berthold Schalke; Wilfred Nix; Reinhard Kiefer; Hans Konrad Müller-Hermelink; Alexander Marx
Selective loss of regulatory T cells in thymomas.
Annals of neurology 2004;56(6):901-4.
2001: Niklas Beyersdorf; Xin Ding; K Karp; Thomas Hanke
Expression of inhibitory "killer cell lectin-like receptor G1" identifies unique subpopulations of effector and memory CD8 T cells.
European journal of immunology 2001;31(12):3443-52.